Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 31/5/2020
SIETES contiene 93020 citas

<< anterior 21 a 40 de 71 siguiente >>
Presentar resultados
Seleccionar todas
21. Cita con resumen
Liu G, Yan Y-P, Zheng X-X, Xu Y-L, Lu J, Hui R-T, Huang X-H. Meta-analysis of nonsteroidal anti-inflammatory drug use and risk of atrial fibrillation. Am J Cardiol 2014;114:1523-9. [Ref.ID 97244]
22. Cita con resumen
Lin CC, Hu HY, Luo JC, Peng YL, Hou MC, Lin HC, Lee FY. Risk factors of gastrointestinal bleeding in clopidogrel users: a nationwide population-based study. Aliment Pharmacol Ther 2013;38:1119-28. [Ref.ID 96272]
23. Cita con resumen
Kuehn BM. FDA warning and study highlight fluoroquinolone risks. JAMA 2013;310:1014. [Ref.ID 96081]
24. Cita con resumen
Lee YC, Lin CH, Wu RM, Lin MS, Lin JW, Chang CH, Lai MS. Discontinuation of statin therapy associates with Parkinson disease: a population-based study. Neurology 2013;81:410-6. [Ref.ID 95841]
25. Cita con resumen
Chung Y-H, Lee Y-C, Chang C-H, Lin M-S, Lin J-W, Lai MS. Statins of high versus low cholesterol-lowering efficacy and the development of severe renal failure. Pharmacoepidemiol Drug Saf 2013;22:583-92. [Ref.ID 95562]
28.Tiene citas relacionadas
29.Tiene citas relacionadas Cita con resumen
Liou J-M, Chen C-C, Chen M-J, Chen C-C, Chang CY, Fang Y-J, Lee J-Y, Hsu S-J, Luo J-C, Chang W-H, Hsu Y-C, Tseng CH, Tseng PH, Wang H-P, Yang U-C, Shun CT, Lin J-T, Lee Y-C, Wu M-S, for the Taiwan Helicobacter Consortium. Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet 2013;381:205-13. [Ref.ID 94796]
30.Tiene citas relacionadas
Greenberg ER, Chey WD. Defining the role of sequential therapy for H pylori infection. Lancet 2013;381:180-2. [Ref.ID 94793]
32.Tiene citas relacionadas Cita con resumen
Wu C-Y, Chen Y-J, Ho HJ, Hsu Y-C, Kup KN, Wu M-S, Lin J-T. Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection. JAMA 2012;308:1906-13. [Ref.ID 94062]
33. Cita con resumen
Anónimo. Serotonergic medicines. Risk of reversible cerebral vasoconstriction syndrome (RCVS). New Zealand. WHO Pharmaceuticals Newsletter 2012;4:11-2. [Ref.ID 93679]
34. Cita con resumen
Gökmen MR, Lord GM. Aristolochic acid nephropathy. BMJ 2012;345:9. [Ref.ID 93447]
35. Cita con resumen
Brefel-Courbon C. Insomnie, hypnotiques et démence. 2012;19:47. [Ref.ID 93271]
36. Cita con resumen
Wang K-L, Liu C-J, Chao T-F, Huang C-M, Wu CH, Chen S-J, Chen T-J, Lin S-J, Chiang C-E. Statins, risk of diabetes, and implications on outcomes in the general population. J Am Coll Cardiol 2012;60:1231-8. [Ref.ID 92921]
37.Tiene citas relacionadas Cita con resumen
Oderda LH, Young JR, Asche CV, Pepper GA. Psychotropic-related hip fractures: meta-analysis of first-generation and second-generation antidepressant and antipsychotic drugs . Ann Pharmacother 2012;46:917-28. [Ref.ID 92714]
38.Tiene citas relacionadas Cita con resumen
Lozano R, Wang H, Foreman KJ, Rajaratnam JK, Naghavi M, Marcus JR, Dwyer-Lindgren L, Lofgren KT, Phillips D, Atkinson C, Lopez AD, Murray CJL. Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis. Lancet 2011;378:1139-65. [Ref.ID 91511]
39.Tiene citas relacionadas
Byass P, Graham WJ. Grappling with uncertainties along the MDG trail. Lancet 2011;378:1119-20. [Ref.ID 91510]
40.Enlace a cita original
Chang C-B, Chen J-H, Wen CJ, Kuo H-K, Lu I-S, Chiu LS, Wu SC, Chan D-C. Potentially inappropriate medications in geriatric out-patients with polypharmacy: application of six sets of published explicit criteria. Br J Clin Pharmacol 2011;72:482-9. [Ref.ID 90995]
Seleccionar todas
<< anterior 21 a 40 de 71 siguiente >>